| Element List | Explanation |
|---|---|
| Introduction | Following the announcement of the Nahdi Medical Company published on Tadawul website on 29-07-2026 corresponding to 15-02-1448, the Company would like to provide further elaboration on its financial results. |
| Date of Posting the Previous Announcement of Development on Saudi Exchange’s Website | 2026-07-29 Corresponding to 1448-02-15 |
| Hyperlink to the Previous Announcement | Click Here |
| Change on the Development | The reason for the decrease in revenue during the current quarter of 2026 compared to the previous quarter is: Revenue: The Company's revenue decreased by 4.3% or SAR 120.2 million to reach SAR 2,674.3 million in the second quarter of 2026 compared to SAR 2,794.4 million in the previous quarter, mainly due to seasonality as the first quarter benefited from the sales uplift associated with Ramadan season. The reason for the decrease in net profit during the current quarter of 2026 compared to the previous quarter is: Net Profit: The Company delivered a net profit of SAR 215.2 million in the second quarter of 2026, compared to SAR 235.7 million in the previous quarter, lower by 8.7% or SAR 20.5 million, mainly due to higher operating expenses incurred to support strategic growth initiatives, healthcare expansion and digital capabilities. |
| Financial Impact on the change | No Impact |
Addendum Announcement from Nahdi Medical Co. Regarding its Interim Financial Results for the Period Ending on 30-06-2026 (Six Months)
AI Summary
- Nahdi Medical Co. reported a net profit of SAR 215.2 million for the second quarter of 2026, representing an 8.7% decrease (SAR 20.5 million) compared to the SAR 235.7 million achieved in the first quarter of 2026.
- Revenue for the quarter totaled SAR 2.67 billion, reflecting a 4.3% sequential decline from SAR 2.79 billion in Q1 2026, which the company attributed to seasonality following the high-sales Ramadan period in the previous quarter.
- The decline in net profit was further driven by increased operating expenses as the company invested in strategic growth initiatives, including healthcare expansion and the strengthening of its digital capabilities.
